D
Adamis Pharmaceuticals Corporation ADMP
$0.22 -$0.0001-0.05%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022 03/31/2022 12/31/2021 09/30/2021
Revenue 1.51M 39.80K 1.15M -1.16M 760.00K
Total Other Revenue -- -- -- -- --
Total Revenue 1.51M 39.80K 1.15M -1.16M 760.00K
Cost of Revenue 1.65M 689.20K 1.46M 1.66M 1.57M
Gross Profit -141.90K -649.30K -309.10K -2.82M -806.00K
SG&A Expenses 2.51M 4.21M 3.38M 4.43M 4.79M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 6.13M 8.22M 9.07M 8.29M 10.98M
Operating Income -4.63M -8.18M -7.91M -9.45M -10.22M
Income Before Tax -4.27M -8.34M -10.19M -7.81M -5.17M
Income Tax Expenses -- -- -- 800.00 --
Earnings from Continuing Operations -4.27M -8.34M -10.19M -7.81M -5.17M
Earnings from Discontinued Operations -127.70K -61.80K -164.90K -961.50K -7.19M
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -4.40M -8.40M -10.35M -8.77M -12.36M
EBIT -4.63M -8.18M -7.91M -9.45M -10.22M
EBITDA -4.23M -7.81M -7.57M -9.08M -9.85M
EPS Basic -0.03 -0.06 -0.07 -0.06 -0.08
Normalized Basic EPS -0.02 -0.04 -0.03 -0.04 -0.04
EPS Diluted -0.03 -0.06 -0.07 -0.06 -0.08
Normalized Diluted EPS -0.02 -0.04 -0.03 -0.04 -0.04
Average Basic Shares Outstanding 149.98M 149.82M 149.62M 149.18M 148.89M
Average Diluted Shares Outstanding 149.98M 149.82M 149.62M 149.18M 148.89M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings